Click for best price
Viral Vaccines Market Size, Share 2022
Market Analysis and Insights: Global Viral Vaccines Market
The global Viral Vaccines market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Viral Vaccines market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Viral Vaccines market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Viral Vaccines market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Viral Vaccines market.
Global Viral Vaccines Scope and Market Size
Viral Vaccines market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Viral Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Segment by Application
- Hospital
- Pharmaceutical Factory
- Research Institute
- Others
By Company
- GSK
- Merck
- Novartis
- Pfizer
- Sanofi
- Bayer
- Zoetis
- AstraZeneca
- Johnson
- CSL
By Region
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- Taiwan
- Indonesia
- Thailand
- Malaysia
- Philippines
- Vietnam
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
The information for each competitor/Company Profile includes:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The content of the study subjects includes a total of 15 chapters:
Chapter 1, describes Viral Vaccines product scope, market overview, market opportunities, market driving force, and market risks.
Chapter 2, profiles the top manufacturers of Viral Vaccines, with price, sales, revenue, and global market share of Viral Vaccines from 2019 to 2022.
Chapter 3, the Viral Vaccines competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Viral Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.
Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Viral Vaccines market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Viral Vaccines.
Chapter 13, 14, and 15, to describe Viral Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Key Indicators Analysed:
- Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
- Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
- Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
- Opportunities and Drivers: Identifying the Growing Demands and New Technology
- Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Reasons to Purchase this Report:
- Estimates 2022-2027 2021-2025 Viral Vaccines Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- 1-year analyst support, along with the data support in excel format.
Research Methodology:
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
| Report Attributes |
Report Details |
| Report Title |
Global Viral Vaccines Market Insights, Forecast to 2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
113 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Study Coverage
1.1 Viral Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Viral Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Attenuated Vaccine
1.2.3 Inactivated Vaccine
1.3 Market by Application
1.3.1 Global Viral Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Pharmaceutical Factory
1.3.4 Research Institute
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Viral Vaccines Sales Estimates and Forecasts 2017-2028
2.2 Global Viral Vaccines Revenue Estimates and Forecasts 2017-2028
2.3 Global Viral Vaccines Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Viral Vaccines Sales by Region
2.4.1 Global Viral Vaccines Sales by Region (2017-2022)
2.4.2 Global Sales Viral Vaccines by Region (2023-2028)
2.5 Global Viral Vaccines Revenue by Region
2.5.1 Global Viral Vaccines Revenue by Region (2017-2022)
2.5.2 Global Viral Vaccines Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Viral Vaccines Sales by Manufacturers
3.1.1 Global Top Viral Vaccines Manufacturers by Sales (2017-2022)
3.1.2 Global Viral Vaccines Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Viral Vaccines in 2021
3.2 Global Viral Vaccines Revenue by Manufacturers
3.2.1 Global Viral Vaccines Revenue by Manufacturers (2017-2022)
3.2.2 Global Viral Vaccines Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Viral Vaccines Revenue in 2021
3.3 Global Viral Vaccines Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Viral Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Viral Vaccines Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Viral Vaccines Sales by Type
4.1.1 Global Viral Vaccines Historical Sales by Type (2017-2022)
4.1.2 Global Viral Vaccines Forecasted Sales by Type (2023-2028)
4.1.3 Global Viral Vaccines Sales Market Share by Type (2017-2028)
4.2 Global Viral Vaccines Revenue by Type
4.2.1 Global Viral Vaccines Historical Revenue by Type (2017-2022)
4.2.2 Global Viral Vaccines Forecasted Revenue by Type (2023-2028)
4.2.3 Global Viral Vaccines Revenue Market Share by Type (2017-2028)
4.3 Global Viral Vaccines Price by Type
4.3.1 Global Viral Vaccines Price by Type (2017-2022)
4.3.2 Global Viral Vaccines Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Viral Vaccines Sales by Application
5.1.1 Global Viral Vaccines Historical Sales by Application (2017-2022)
5.1.2 Global Viral Vaccines Forecasted Sales by Application (2023-2028)
5.1.3 Global Viral Vaccines Sales Market Share by Application (2017-2028)
5.2 Global Viral Vaccines Revenue by Application
5.2.1 Global Viral Vaccines Historical Revenue by Application (2017-2022)
5.2.2 Global Viral Vaccines Forecasted Revenue by Application (2023-2028)
5.2.3 Global Viral Vaccines Revenue Market Share by Application (2017-2028)
5.3 Global Viral Vaccines Price by Application
5.3.1 Global Viral Vaccines Price by Application (2017-2022)
5.3.2 Global Viral Vaccines Price Forecast by Application (2023-2028)
6 North America
6.1 North America Viral Vaccines Market Size by Type
6.1.1 North America Viral Vaccines Sales by Type (2017-2028)
6.1.2 North America Viral Vaccines Revenue by Type (2017-2028)
6.2 North America Viral Vaccines Market Size by Application
6.2.1 North America Viral Vaccines Sales by Application (2017-2028)
6.2.2 North America Viral Vaccines Revenue by Application (2017-2028)
6.3 North America Viral Vaccines Market Size by Country
6.3.1 North America Viral Vaccines Sales by Country (2017-2028)
6.3.2 North America Viral Vaccines Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Viral Vaccines Market Size by Type
7.1.1 Europe Viral Vaccines Sales by Type (2017-2028)
7.1.2 Europe Viral Vaccines Revenue by Type (2017-2028)
7.2 Europe Viral Vaccines Market Size by Application
7.2.1 Europe Viral Vaccines Sales by Application (2017-2028)
7.2.2 Europe Viral Vaccines Revenue by Application (2017-2028)
7.3 Europe Viral Vaccines Market Size by Country
7.3.1 Europe Viral Vaccines Sales by Country (2017-2028)
7.3.2 Europe Viral Vaccines Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Viral Vaccines Market Size by Type
8.1.1 Asia Pacific Viral Vaccines Sales by Type (2017-2028)
8.1.2 Asia Pacific Viral Vaccines Revenue by Type (2017-2028)
8.2 Asia Pacific Viral Vaccines Market Size by Application
8.2.1 Asia Pacific Viral Vaccines Sales by Application (2017-2028)
8.2.2 Asia Pacific Viral Vaccines Revenue by Application (2017-2028)
8.3 Asia Pacific Viral Vaccines Market Size by Region
8.3.1 Asia Pacific Viral Vaccines Sales by Region (2017-2028)
8.3.2 Asia Pacific Viral Vaccines Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Viral Vaccines Market Size by Type
9.1.1 Latin America Viral Vaccines Sales by Type (2017-2028)
9.1.2 Latin America Viral Vaccines Revenue by Type (2017-2028)
9.2 Latin America Viral Vaccines Market Size by Application
9.2.1 Latin America Viral Vaccines Sales by Application (2017-2028)
9.2.2 Latin America Viral Vaccines Revenue by Application (2017-2028)
9.3 Latin America Viral Vaccines Market Size by Country
9.3.1 Latin America Viral Vaccines Sales by Country (2017-2028)
9.3.2 Latin America Viral Vaccines Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Viral Vaccines Market Size by Type
10.1.1 Middle East and Africa Viral Vaccines Sales by Type (2017-2028)
10.1.2 Middle East and Africa Viral Vaccines Revenue by Type (2017-2028)
10.2 Middle East and Africa Viral Vaccines Market Size by Application
10.2.1 Middle East and Africa Viral Vaccines Sales by Application (2017-2028)
10.2.2 Middle East and Africa Viral Vaccines Revenue by Application (2017-2028)
10.3 Middle East and Africa Viral Vaccines Market Size by Country
10.3.1 Middle East and Africa Viral Vaccines Sales by Country (2017-2028)
10.3.2 Middle East and Africa Viral Vaccines Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 GSK
11.1.1 GSK Corporation Information
11.1.2 GSK Overview
11.1.3 GSK Viral Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 GSK Viral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 GSK Recent Developments
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Overview
11.2.3 Merck Viral Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Merck Viral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Merck Recent Developments
11.3 Novartis
11.3.1 Novartis Corporation Information
11.3.2 Novartis Overview
11.3.3 Novartis Viral Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Novartis Viral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Novartis Recent Developments
11.4 Pfizer
11.4.1 Pfizer Corporation Information
11.4.2 Pfizer Overview
11.4.3 Pfizer Viral Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Pfizer Viral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Pfizer Recent Developments
11.5 Sanofi
11.5.1 Sanofi Corporation Information
11.5.2 Sanofi Overview
11.5.3 Sanofi Viral Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Sanofi Viral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Sanofi Recent Developments
11.6 Bayer
11.6.1 Bayer Corporation Information
11.6.2 Bayer Overview
11.6.3 Bayer Viral Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Bayer Viral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Bayer Recent Developments
11.7 Zoetis
11.7.1 Zoetis Corporation Information
11.7.2 Zoetis Overview
11.7.3 Zoetis Viral Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Zoetis Viral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Zoetis Recent Developments
11.8 AstraZeneca
11.8.1 AstraZeneca Corporation Information
11.8.2 AstraZeneca Overview
11.8.3 AstraZeneca Viral Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 AstraZeneca Viral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 AstraZeneca Recent Developments
11.9 Johnson
11.9.1 Johnson Corporation Information
11.9.2 Johnson Overview
11.9.3 Johnson Viral Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Johnson Viral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Johnson Recent Developments
11.10 CSL
11.10.1 CSL Corporation Information
11.10.2 CSL Overview
11.10.3 CSL Viral Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 CSL Viral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 CSL Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Viral Vaccines Industry Chain Analysis
12.2 Viral Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Viral Vaccines Production Mode & Process
12.4 Viral Vaccines Sales and Marketing
12.4.1 Viral Vaccines Sales Channels
12.4.2 Viral Vaccines Distributors
12.5 Viral Vaccines Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Viral Vaccines Industry Trends
13.2 Viral Vaccines Market Drivers
13.3 Viral Vaccines Market Challenges
13.4 Viral Vaccines Market Restraints
14 Key Findings in The Global Viral Vaccines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Global Viral Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Attenuated Vaccine
Table 3. Major Manufacturers of Inactivated Vaccine
Table 4. Global Viral Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Viral Vaccines Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Viral Vaccines Sales by Region (2017-2022) & (K MT)
Table 7. Global Viral Vaccines Sales Market Share by Region (2017-2022)
Table 8. Global Viral Vaccines Sales by Region (2023-2028) & (K MT)
Table 9. Global Viral Vaccines Sales Market Share by Region (2023-2028)
Table 10. Global Viral Vaccines Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Viral Vaccines Revenue Market Share by Region (2017-2022)
Table 12. Global Viral Vaccines Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Viral Vaccines Revenue Market Share by Region (2023-2028)
Table 14. Global Viral Vaccines Sales by Manufacturers (2017-2022) & (K MT)
Table 15. Global Viral Vaccines Sales Share by Manufacturers (2017-2022)
Table 16. Global Viral Vaccines Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Viral Vaccines Revenue Share by Manufacturers (2017-2022)
Table 18. Viral Vaccines Price by Manufacturers (2017-2022) &(USD/MT)
Table 19. Global Viral Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Viral Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vaccines as of 2021)
Table 21. Viral Vaccines Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Viral Vaccines Product Offered
Table 23. Date of Manufacturers Enter into Viral Vaccines Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Viral Vaccines Sales by Type (2017-2022) & (K MT)
Table 26. Global Viral Vaccines Sales by Type (2023-2028) & (K MT)
Table 27. Global Viral Vaccines Sales Share by Type (2017-2022)
Table 28. Global Viral Vaccines Sales Share by Type (2023-2028)
Table 29. Global Viral Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Viral Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Viral Vaccines Revenue Share by Type (2017-2022)
Table 32. Global Viral Vaccines Revenue Share by Type (2023-2028)
Table 33. Viral Vaccines Price by Type (2017-2022) & (USD/MT)
Table 34. Global Viral Vaccines Price Forecast by Type (2023-2028) & (USD/MT)
Table 35. Global Viral Vaccines Sales by Application (2017-2022) & (K MT)
Table 36. Global Viral Vaccines Sales by Application (2023-2028) & (K MT)
Table 37. Global Viral Vaccines Sales Share by Application (2017-2022)
Table 38. Global Viral Vaccines Sales Share by Application (2023-2028)
Table 39. Global Viral Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Viral Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Viral Vaccines Revenue Share by Application (2017-2022)
Table 42. Global Viral Vaccines Revenue Share by Application (2023-2028)
Table 43. Viral Vaccines Price by Application (2017-2022) & (USD/MT)
Table 44. Global Viral Vaccines Price Forecast by Application (2023-2028) & (USD/MT)
Table 45. North America Viral Vaccines Sales by Type (2017-2022) & (K MT)
Table 46. North America Viral Vaccines Sales by Type (2023-2028) & (K MT)
Table 47. North America Viral Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Viral Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Viral Vaccines Sales by Application (2017-2022) & (K MT)
Table 50. North America Viral Vaccines Sales by Application (2023-2028) & (K MT)
Table 51. North America Viral Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Viral Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Viral Vaccines Sales by Country (2017-2022) & (K MT)
Table 54. North America Viral Vaccines Sales by Country (2023-2028) & (K MT)
Table 55. North America Viral Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Viral Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Viral Vaccines Sales by Type (2017-2022) & (K MT)
Table 58. Europe Viral Vaccines Sales by Type (2023-2028) & (K MT)
Table 59. Europe Viral Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Viral Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Viral Vaccines Sales by Application (2017-2022) & (K MT)
Table 62. Europe Viral Vaccines Sales by Application (2023-2028) & (K MT)
Table 63. Europe Viral Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Viral Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Viral Vaccines Sales by Country (2017-2022) & (K MT)
Table 66. Europe Viral Vaccines Sales by Country (2023-2028) & (K MT)
Table 67. Europe Viral Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Viral Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Viral Vaccines Sales by Type (2017-2022) & (K MT)
Table 70. Asia Pacific Viral Vaccines Sales by Type (2023-2028) & (K MT)
Table 71. Asia Pacific Viral Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Viral Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Viral Vaccines Sales by Application (2017-2022) & (K MT)
Table 74. Asia Pacific Viral Vaccines Sales by Application (2023-2028) & (K MT)
Table 75. Asia Pacific Viral Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Viral Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Viral Vaccines Sales by Region (2017-2022) & (K MT)
Table 78. Asia Pacific Viral Vaccines Sales by Region (2023-2028) & (K MT)
Table 79. Asia Pacific Viral Vaccines Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Viral Vaccines Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Viral Vaccines Sales by Type (2017-2022) & (K MT)
Table 82. Latin America Viral Vaccines Sales by Type (2023-2028) & (K MT)
Table 83. Latin America Viral Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Viral Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Viral Vaccines Sales by Application (2017-2022) & (K MT)
Table 86. Latin America Viral Vaccines Sales by Application (2023-2028) & (K MT)
Table 87. Latin America Viral Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Viral Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Viral Vaccines Sales by Country (2017-2022) & (K MT)
Table 90. Latin America Viral Vaccines Sales by Country (2023-2028) & (K MT)
Table 91. Latin America Viral Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Viral Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Viral Vaccines Sales by Type (2017-2022) & (K MT)
Table 94. Middle East and Africa Viral Vaccines Sales by Type (2023-2028) & (K MT)
Table 95. Middle East and Africa Viral Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Viral Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Viral Vaccines Sales by Application (2017-2022) & (K MT)
Table 98. Middle East and Africa Viral Vaccines Sales by Application (2023-2028) & (K MT)
Table 99. Middle East and Africa Viral Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Viral Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Viral Vaccines Sales by Country (2017-2022) & (K MT)
Table 102. Middle East and Africa Viral Vaccines Sales by Country (2023-2028) & (K MT)
Table 103. Middle East and Africa Viral Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Viral Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 105. GSK Corporation Information
Table 106. GSK Description and Major Businesses
Table 107. GSK Viral Vaccines Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 108. GSK Viral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. GSK Recent Developments
Table 110. Merck Corporation Information
Table 111. Merck Description and Major Businesses
Table 112. Merck Viral Vaccines Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 113. Merck Viral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Merck Recent Developments
Table 115. Novartis Corporation Information
Table 116. Novartis Description and Major Businesses
Table 117. Novartis Viral Vaccines Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 118. Novartis Viral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Novartis Recent Developments
Table 120. Pfizer Corporation Information
Table 121. Pfizer Description and Major Businesses
Table 122. Pfizer Viral Vaccines Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 123. Pfizer Viral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Pfizer Recent Developments
Table 125. Sanofi Corporation Information
Table 126. Sanofi Description and Major Businesses
Table 127. Sanofi Viral Vaccines Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 128. Sanofi Viral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Sanofi Recent Developments
Table 130. Bayer Corporation Information
Table 131. Bayer Description and Major Businesses
Table 132. Bayer Viral Vaccines Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 133. Bayer Viral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Bayer Recent Developments
Table 135. Zoetis Corporation Information
Table 136. Zoetis Description and Major Businesses
Table 137. Zoetis Viral Vaccines Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 138. Zoetis Viral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Zoetis Recent Developments
Table 140. AstraZeneca Corporation Information
Table 141. AstraZeneca Description and Major Businesses
Table 142. AstraZeneca Viral Vaccines Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 143. AstraZeneca Viral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. AstraZeneca Recent Developments
Table 145. Johnson Corporation Information
Table 146. Johnson Description and Major Businesses
Table 147. Johnson Viral Vaccines Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 148. Johnson Viral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Johnson Recent Developments
Table 150. CSL Corporation Information
Table 151. CSL Description and Major Businesses
Table 152. CSL Viral Vaccines Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 153. CSL Viral Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. CSL Recent Developments
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Viral Vaccines Distributors List
Table 158. Viral Vaccines Customers List
Table 159. Viral Vaccines Market Trends
Table 160. Viral Vaccines Market Drivers
Table 161. Viral Vaccines Market Challenges
Table 162. Viral Vaccines Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Viral Vaccines Product Picture
Figure 3. Global Viral Vaccines Market Share by Type in 2021 & 2028
Figure 3. Attenuated Vaccine Product Picture
Figure 4. Inactivated Vaccine Product Picture
Figure 5. Global Viral Vaccines Market Share by Application in 2021 & 2028
Figure 6. Hospital
Figure 7. Pharmaceutical Factory
Figure 8. Research Institute
Figure 9. Others
Figure 10. Viral Vaccines Report Years Considered
Figure 11. Global Viral Vaccines Sales 2017-2028 (K MT)
Figure 12. Global Viral Vaccines Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Viral Vaccines Revenue 2017-2028 (US$ Million)
Figure 14. Global Viral Vaccines Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Viral Vaccines Sales Market Share by Region (2017-2022)
Figure 16. Global Viral Vaccines Sales Market Share by Region (2023-2028)
Figure 17. North America Viral Vaccines Sales YoY (2017-2028) & (K MT)
Figure 18. North America Viral Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Viral Vaccines Sales YoY (2017-2028) & (K MT)
Figure 20. Europe Viral Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Viral Vaccines Sales YoY (2017-2028) & (K MT)
Figure 22. Asia-Pacific Viral Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Viral Vaccines Sales YoY (2017-2028) & (K MT)
Figure 24. Latin America Viral Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Viral Vaccines Sales YoY (2017-2028) & (K MT)
Figure 26. Middle East & Africa Viral Vaccines Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Viral Vaccines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Viral Vaccines in the World: Market Share by Viral Vaccines Revenue in 2021
Figure 29. Global Viral Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Viral Vaccines Sales Market Share by Type (2017-2028)
Figure 31. Global Viral Vaccines Revenue Market Share by Type (2017-2028)
Figure 32. Global Viral Vaccines Sales Market Share by Application (2017-2028)
Figure 33. Global Viral Vaccines Revenue Market Share by Application (2017-2028)
Figure 34. North America Viral Vaccines Sales Market Share by Type (2017-2028)
Figure 35. North America Viral Vaccines Revenue Market Share by Type (2017-2028)
Figure 36. North America Viral Vaccines Sales Market Share by Application (2017-2028)
Figure 37. North America Viral Vaccines Revenue Market Share by Application (2017-2028)
Figure 38. North America Viral Vaccines Sales Share by Country (2017-2028)
Figure 39. North America Viral Vaccines Revenue Share by Country (2017-2028)
Figure 40. U.S. Viral Vaccines Revenue (2017-2028) & (US$ Million)
Figure 41. Canada Viral Vaccines Revenue (2017-2028) & (US$ Million)
Figure 42. Europe Viral Vaccines Sales Market Share by Type (2017-2028)
Figure 43. Europe Viral Vaccines Revenue Market Share by Type (2017-2028)
Figure 44. Europe Viral Vaccines Sales Market Share by Application (2017-2028)
Figure 45. Europe Viral Vaccines Revenue Market Share by Application (2017-2028)
Figure 46. Europe Viral Vaccines Sales Share by Country (2017-2028)
Figure 47. Europe Viral Vaccines Revenue Share by Country (2017-2028)
Figure 48. Germany Viral Vaccines Revenue (2017-2028) & (US$ Million)
Figure 49. France Viral Vaccines Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. Viral Vaccines Revenue (2017-2028) & (US$ Million)
Figure 51. Italy Viral Vaccines Revenue (2017-2028) & (US$ Million)
Figure 52. Russia Viral Vaccines Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific Viral Vaccines Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific Viral Vaccines Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific Viral Vaccines Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific Viral Vaccines Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific Viral Vaccines Sales Share by Region (2017-2028)
Figure 58. Asia Pacific Viral Vaccines Revenue Share by Region (2017-2028)
Figure 59. China Viral Vaccines Revenue (2017-2028) & (US$ Million)
Figure 60. Japan Viral Vaccines Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea Viral Vaccines Revenue (2017-2028) & (US$ Million)
Figure 62. India Viral Vaccines Revenue (2017-2028) & (US$ Million)
Figure 63. Australia Viral Vaccines Revenue (2017-2028) & (US$ Million)
Figure 64. Taiwan Viral Vaccines Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia Viral Vaccines Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand Viral Vaccines Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia Viral Vaccines Revenue (2017-2028) & (US$ Million)
Figure 68. Philippines Viral Vaccines Revenue (2017-2028) & (US$ Million)
Figure 69. Latin America Viral Vaccines Sales Market Share by Type (2017-2028)
Figure 70. Latin America Viral Vaccines Revenue Market Share by Type (2017-2028)
Figure 71. Latin America Viral Vaccines Sales Market Share by Application (2017-2028)
Figure 72. Latin America Viral Vaccines Revenue Market Share by Application (2017-2028)
Figure 73. Latin America Viral Vaccines Sales Share by Country (2017-2028)
Figure 74. Latin America Viral Vaccines Revenue Share by Country (2017-2028)
Figure 75. Mexico Viral Vaccines Revenue (2017-2028) & (US$ Million)
Figure 76. Brazil Viral Vaccines Revenue (2017-2028) & (US$ Million)
Figure 77. Argentina Viral Vaccines Revenue (2017-2028) & (US$ Million)
Figure 78. Middle East and Africa Viral Vaccines Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Viral Vaccines Revenue Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Viral Vaccines Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Viral Vaccines Revenue Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Viral Vaccines Sales Share by Country (2017-2028)
Figure 83. Middle East and Africa Viral Vaccines Revenue Share by Country (2017-2028)
Figure 84. Turkey Viral Vaccines Revenue (2017-2028) & (US$ Million)
Figure 85. Saudi Arabia Viral Vaccines Revenue (2017-2028) & (US$ Million)
Figure 86. UAE Viral Vaccines Revenue (2017-2028) & (US$ Million)
Figure 87. Viral Vaccines Value Chain
Figure 88. Viral Vaccines Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed
